11032 Federal Register / Vol. 66, No. 35 / Wednesday, February 21, 2001 / Notices

Dated: February 15, 2001.

Karl J. Sandstrom,

Commissioner, Federal Election Commission.

[FR Doc. 01–4246 Filed 2–20–01; 8:45 am]

BILLING CODE 6715–01–P

FEDERAL RESERVE SYSTEM

Change in Bank Control Notices;

Acquisitions of Shares of Banks or

Bank Holding Companies

The notificants listed below have

applied under the Change in Bank

Control Act (12 U.S.C. 1817(j)) and

§ 225.41 of the Board’s Regulation Y (12

CFR 225.41) to acquire a bank or bank

holding company. The factors that are

considered in acting on the notices are

set forth in paragraph 7 of the Act (12

U.S.C. 1817(j)(7)).

The notices are available for

immediate inspection at the Federal

Reserve Bank indicated. The notices

also will be available for inspection at

the offices of the Board of Governors.

Interested persons may express their

views in writing to the Reserve Bank

indicated for that notice or to the offices

of the Board of Governors. Comments

must be received not later than March

6, 2001.

A. Federal Reserve Bank of Kansas

City (D. Michael Manies, Assistant Vice

President) 925 Grand Avenue, Kansas

City, Missouri 64198–0001:

1. David Jackson Swearingen and

Susan Gail Swearingen, Nevada,

Missouri; to acquire voting shares of

1889 Bancshares, Inc., Nevada,

Missouri, and thereby indirectly acquire

voting shares of First National Bank of

Nevada, Nevada, Missouri.

Board of Governors of the Federal Reserve

System, February 14, 2001.

Robert deV. Frierson,

Associate Secretary of the Board.

[FR Doc. 01–4172 Filed 2–20–01; 8:45 am]

BILLING CODE 6210–01–P

BOARD OF GOVERNORS OF THE

FEDERAL RESERVE SYSTEM

Government in the Sunshine; Meeting

Notice

AGENCY HOLDING THE MEETING: Board of

Governors of the Federal Reserve

System.

TIME AND DATE: 11 a.m., Monday,

February 26, 2001.

PLACE: Marriner S. Eccles Federal

Reserve Board Building, 20th and C

Streets, NW., Washington, DC 20551.

STATUS: Closed.

MATTERS TO BE CONSIDERED:

1. Personnel actions (appointments,

promotions, assignments,

reassignments, and salary actions)

involving individual Federal Reserve

System employees.

2. Any items carried forward from a

previously announced meeting.

CONTACT PERSON FOR MORE INFORMATION:

Lynn S. Fox, Assistant to the Board;

202–452–3204.

SUPPLEMENTARY INFORMATION: You may

call 202–452–3206 beginning at

approximately 5 p.m. two business days

before the meeting for a recorded

announcement of bank and bank

holding company applications

scheduled for the meeting; or you may

contact the Board’s Web site at http://

www.federalreserve.gov for an electronic

announcement that not only lists

applications, but also indicates

procedural and other information about

the meeting.

Dated: February 16, 2001.

Jennifer J. Johnson,

Secretary of the Board.

[FR Doc. 01–4447 Filed 2–16–01; 5:04 pm]

BILLING CODE 6210–01–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Notice of Meeting of the Advisory

Committee on Blood Safety and

Availability

AGENCY: Office of the Secretary, HHS.

ACTION: Notice of meeting.

The Advisory Committee on Blood

Safety and Availability will meet on

Thursday April 19, 2001 and Friday

April 20, 2001 from 8 a.m. to 5 p.m. The

meeting will take place at the Hyatt

Regency Hotel on Capitol Hill, 400 New

Jersey Ave., NW., Washington, DC

20001. The meeting will be entirely

open to the public.

The first item on the agenda will be

what should be the Department’s

current and future actions under its

Blood Action Plan to monitor the

availability of blood products in the

United States. Specific comment will be

solicited on what parameters should be

monitored, how these parameters

should be analyzed, and where

responsibility for this activity should

rest.

The second item on the agenda will

be what, if any, actions the Department

of Health and Human Services should

take to strengthen current efforts to

promote blood safety and availability

throughout the world.

Public comment will be solicited at

the meeting. Public comment will be

limited to five minutes per speaker.

Those who wish to have printed

material distributed to Advisory

Committee members should submit

thirty (30) copies to the Executive

Secretary prior to close of business

April 5, 2001. In addition, anyone

planning to comment on either item is

encouraged to contact the Executive

Secretary at his/her earliest

convenience.

FOR FURTHER INFORMATION CONTACT:

Stephen D. Nightingale, M.D., Executive

Secretary, Advisory Committee on

Blood Safety and Availability,

Department of Health and Human

Services, Office of Public Health and

Science, 200 Independence Ave., SW.,

Room 736–E, Washington, DC 20201.

Phone (202) 690–5560. FAX (202) 690–

7560, e-mail

StephenDNightingale@osophs.dhhs.gov.

Dated: February 13, 2001.

Stephen D. Nightingale,

Executive Secretary Advisory Committee on

Blood Safety and Availability.

[FR Doc. 01–4243 Filed 2–20–01; 8:45 am]

BILLING CODE 4160–17–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Office of the Secretary

PHS Policy on Instruction in the

Responsible Conduct of Research

AGENCY: Office of the Secretary, HHS.

ACTION: Notice of suspension of ‘‘PHS

Policy on Instruction in the Responsible

Conduct of Research.’’

SUMMARY: On December 7, 2000, the

Office of Research Integrity (ORI), in

collaboration with each of the Public

Health Service (PHS) Operating

Divisions, announced in the Federal

Register the issuance of a Final Policy

on Instruction in the Responsible

Conduct of Research. 65 FR 76647. A

Draft PHS Policy on Instruction in the

Responsible Conduct of Research was

announced in the Federal Register on

July 21, 2000, and made available for

public comment until September 21,

2000. In response to the public

comment, ORI and the PHS agencies

made substantial revisions to the draft

policy before its issuance in final form.

Consistent with the President’s

January 20, 2001, Regulatory Review

Plan, on behalf of PHS, ORI hereby

suspends implementation of the ‘‘PHS

Policy on Instruction in the Responsible

Conduct of Research’’ to permit

additional review both of the substance

of the policy and the process for

adoption. Pending completion of that